Stock Track | REMEGEN Soars 8.86% Amid Broader Biotech Rally in Hong Kong

Stock Track
2025/08/29

REMEGEN (09995) experienced a significant surge in its stock price, soaring 8.86% during Friday's trading session in Hong Kong. This impressive gain comes as part of a broader rally in the biotech sector, with several companies in the industry posting substantial increases.

The biotech sector in Hong Kong saw widespread gains, with companies like Cutia Therapeutics leading the pack with a 14% increase. Other notable performers included Antengene (up 13%), HBM Holdings and TransThera Sciences (both up 9%), and CARsgen Therapeutics (up 7%). REMEGEN's 8.86% rise positioned it firmly among the top performers in this sector-wide upswing, reflecting strong investor confidence in the biotech industry and REMEGEN's potential within it.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10